← Open Payments lookup

LAURA STEVENS: Open Payments

NPI 1457815235 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,827 in 149 payments from 22 companies in 2025. Trend: 2023 $2,889 · 2024 $2,950 · 2025 $2,827

Food & beverage: $2,827
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP31$717
GlaxoSmithKline, LLC.26$308
United Therapeutics Corporation12$258
Grifols USA, LLC10$232
Boehringer Ingelheim Pharmaceuticals, Inc.10$182
GENZYME CORPORATION9$166
Verona Pharma, Inc.9$166
Merck Sharp & Dohme LLC7$165
Regeneron Healthcare Solutions, Inc.4$94
Takeda Pharmaceuticals U.S.A., Inc.3$67

Products named: DUPIXENT, TEZSPIRE, Tyvaso, FASENRA, Prolastin-C Liquid, TRELEGY ELLIPTA, Ohtuvayre, NUCALA.

Industry payments across MS — which companies pay providers there.